Prediction Case File
YouTubeEvaluation Complete

Novo Nordisk A/S Stock Prediction and Forecast [NVO]

1 extracted signal · 1 resolved · 0 still active

StockInvest.us profile imageStockInvest.usIndependent analyst profile
Source published
15 Jan 2026, 04:30 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Novo Nordisk A/S Stock Prediction and Forecast [NVO]
Source overview

AI-generated source summary

The analysis focuses on Novo Nordisk A/S (NVO), with an initial report on January 14th, 2026, classifying it as a "Buy Candidate" with a score of 1.98. The stock has shown a 4.75% gain over the past 7 days, averaging 0.68% daily, and an overall 15.01% rise in the last two weeks. Short-term trends indicate the stock is in a broad rising trend, though a selling opportunity for short-term traders is also suggested. Technical indicators like MACD, Bollinger Bands, and some Moving Averages signal a buy, while Pivots and the Short Moving Average indicate a sell, with a pivot top sell signal on January 12th, 2026. Support levels are identified at $58.20 and $51.09, with resistance at $59.64. The stock exhibits high weekly volatility of 2.34%, with an RSI14 of 79, indicating high risk. The suggested stop-loss is set at $56.56. The P/E ratio is 16.20. The 12-month outlook forecasts a significant negative change of 38.27%. However, the conclusion points to a short-term buying opportunity, anticipating NVO to open higher by $0.09 at $59.00 on January 15th, and is considered undervalued.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Analyst snapshot

StockInvest.us

Platform-wide history, separate from this source evaluation.

Reliability
53.4
Tracked signals
1779
Historical success
42.8%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail